Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. more
| Time Frame | BBC | S&P500 |
|---|---|---|
| 1-Week Return | 0.69% | 0.01% |
| 1-Month Return | 30.72% | 3.54% |
| 3-Month Return | 22.5% | 10.58% |
| 6-Month Return | 35.05% | 8.03% |
| 1-Year Return | 146.93% | 20.06% |
| 3-Year Return | 117.88% | 70.98% |
| 5-Year Return | 8.39% | 71.89% |
| 10-Year Return | 178.06% | 252.66% |
| Time Frame | BBC | S&P500 |
|---|---|---|
| 1-Week Return | 43.13% | 0.52% |
| 1-Month Return | 2,503.12% | 52.69% |
| 3-Month Return | 127.74% | 50.36% |
| 6-Month Return | 83.91% | 16.96% |
| 1-Year Return | 146.93% | 20.06% |
| 3-Year Return | 29.64% | 19.58% |
| 5-Year Return | 1.62% | 11.44% |
| 10-Year Return | 10.77% | 13.43% |
| Stock name | Ticker | Weight |
|---|---|---|
REGENXBIO Inc
|
RGNX |
1.4%
|
Definium Therapeutics Inc
|
DFTX |
1.17%
|
MBX Biosciences Inc
|
MBX |
1.1%
|
First Tracks Biotherapeutics Inc
|
TRAX |
1.1%
|
Monopar Therapeutics Inc
|
MNPR |
1.04%
|
SELLAS Life Sciences Group Inc
|
SLS |
1.03%
|
uniQure NV
|
QURE |
0.96%
|
Solid Biosciences Inc
|
SLDB |
0.93%
|
Prime Medicine Inc
|
PRME |
0.91%
|
Rocket Pharmaceuticals Inc
|
RCKT |
0.91%
|
Apogee Therapeutics Inc
|
APGE |
0.9%
|
Biohaven Ltd
|
BHVN |
0.89%
|
Zenas Biopharma Inc
|
ZBIO |
0.89%
|
Damora Therapeutics Inc
|
DMRA |
0.88%
|
Neurogene Inc
|
NGNE |
0.88%
|
Sana Biotechnology Inc
|
SANA |
0.88%
|
Jade Biosciences Inc
|
JBIO |
0.87%
|
4D Molecular Therapeutics Inc
|
FDMT |
0.87%
|
Nurix Therapeutics Inc
|
NRIX |
0.87%
|
MeiraGTx Holdings plc
|
MGTX |
0.87%
|
MapLight Therapeutics Inc
|
MPLT |
0.86%
|
Viking Therapeutics Inc
|
VKTX |
0.85%
|
Design Therapeutics Inc
|
DSGN |
0.84%
|
Relay Therapeutics Inc
|
RLAY |
0.84%
|
AbCellera Biologics Inc
|
ABCL |
0.83%
|
Edgewise Therapeutics Inc
|
EWTX |
0.83%
|
Palvella Therapeutics Inc
|
PVLA |
0.83%
|
Kymera Therapeutics Inc
|
KYMR |
0.82%
|
BioAge Labs Inc
|
BIOA |
0.82%
|
Vor BioPharma Inc
|
VOR |
0.82%
|
Bicara Therapeutics Inc
|
BCAX |
0.82%
|
Erasca Inc
|
ERAS |
0.81%
|
Xenon Pharmaceuticals Inc
|
XENE |
0.81%
|
AtaiBeckley Inc
|
ATAI |
0.81%
|
Corvus Pharmaceuticals Inc
|
CRVS |
0.81%
|
Avalo Therapeutics Inc
|
AVTX |
0.81%
|
Maze Therapeutics Inc
|
MAZE |
0.8%
|
Monte Rosa Therapeutics Inc
|
GLUE |
0.8%
|
Cullinan Therapeutics Inc
|
CGEM |
0.8%
|
Dyne Therapeutics Inc
|
DYN |
0.8%
|
ORIC Pharmaceuticals Inc
|
ORIC |
0.79%
|
Immunome Inc
|
IMNM |
0.78%
|
CytomX Therapeutics Inc
|
CTMX |
0.78%
|
Immix Biopharma Inc
|
IMMX |
0.78%
|
Scholar Rock Holding Corp
|
SRRK |
0.78%
|
Xencor Inc
|
XNCR |
0.78%
|
VeraDermics Inc
|
MANE |
0.78%
|
Aktis Oncology Inc
|
AKTS |
0.77%
|
GH Research PLC
|
GHRS |
0.77%
|
Alto Neuroscience Inc
|
ANRO |
0.77%
|
Ideaya Biosciences Inc
|
IDYA |
0.77%
|
Structure Therapeutics Inc
|
GPCR |
0.77%
|
Rezolute Inc
|
RZLT |
0.77%
|
Celcuity Inc
|
CELC |
0.77%
|
Upstream Bio Inc
|
UPB |
0.76%
|
Intellia Therapeutics Inc
|
NTLA |
0.76%
|
Generate Biomedicines Inc
|
GENB |
0.76%
|
Oruka Therapeutics Inc
|
ORKA |
0.75%
|
Annexon Inc
|
ANNX |
0.75%
|
Vaxcyte Inc
|
PCVX |
0.75%
|
Amylyx Pharmaceuticals Inc
|
AMLX |
0.75%
|
Arcus Biosciences Inc
|
RCUS |
0.75%
|
Alumis Inc
|
ALMS |
0.75%
|
Replimune Group Inc
|
REPL |
0.75%
|
Sionna Therapeutics Inc
|
SION |
0.75%
|
Praxis Precision Medicines Inc
|
PRAX |
0.75%
|
Celldex Therapeutics Inc
|
CLDX |
0.74%
|
Olema Pharmaceuticals Inc
|
OLMA |
0.74%
|
Revolution Medicines Inc
|
RVMD |
0.74%
|
Vera Therapeutics Inc
|
VERA |
0.74%
|
Viridian Therapeutics Inc
|
VRDN |
0.74%
|
Oculis Holding AG
|
OCS |
0.74%
|
Janux Therapeutics Inc
|
JANX |
0.74%
|
Beam Therapeutics Inc
|
BEAM |
0.74%
|
CG oncology Inc
|
CGON |
0.73%
|
Nektar Therapeutics
|
NKTR |
0.73%
|
Mineralys Therapeutics Inc
|
MLYS |
0.73%
|
Cogent Biosciences Inc
|
COGT |
0.73%
|
Tyra Biosciences Inc
|
TYRA |
0.73%
|
Spyre Therapeutics Inc
|
SYRE |
0.73%
|
Immunovant Inc
|
IMVT |
0.73%
|
Dianthus Therapeutics Inc
|
DNTH |
0.73%
|
Assembly Biosciences Inc
|
ASMB |
0.72%
|
Climb Bio Inc
|
CLYM |
0.72%
|
Arbutus Biopharma Corp
|
ABUS |
0.72%
|
Vir Biotechnology Inc
|
VIR |
0.72%
|
Savara Inc
|
SVRA |
0.71%
|
Altimmune Inc
|
ALT |
0.71%
|
Recursion Pharmaceuticals Inc
|
RXRX |
0.71%
|
AnaptysBio Inc
|
ANAB |
0.71%
|
LB Pharmaceuticals Inc
|
LBRX |
0.71%
|
Newamsterdam Pharma Co NV
|
NAMS |
0.71%
|
Kodiak Sciences Inc
|
KOD |
0.7%
|
BridgeBio Oncology Therapeutics Inc
|
BBOT |
0.7%
|
Lexicon Pharmaceuticals Inc
|
LXRX |
0.7%
|
Pharvaris NV
|
PHVS |
0.7%
|
Prothena Corp PLC
|
PRTA |
0.7%
|
Tectonic Therapeutic Inc
|
TECX |
0.7%
|
Disc Medicine Inc
|
IRON |
0.69%
|
Achieve Life Sciences Inc
|
ACHV |
0.69%
|
Lexeo Therapeutics Inc
|
LXEO |
0.69%
|
Candel Therapeutics Inc
|
CADL |
0.69%
|
Taysha Gene Therapies Inc
|
TSHA |
0.69%
|
EyePoint Inc
|
EYPT |
0.68%
|
Compass Therapeutics Inc
|
CMPX |
0.68%
|
Enliven Therapeutics Inc
|
ELVN |
0.68%
|
Arvinas Inc
|
ARVN |
0.67%
|
Inhibrx Biosciences Inc
|
INBX |
0.67%
|
Compass Pathways Plc
|
CMPS |
0.67%
|
Belite Bio Inc
|
BLTE |
0.66%
|
Allogene Therapeutics Inc
|
ALLO |
0.66%
|
Summit Therapeutics Inc
|
SMMT |
0.66%
|
ArriVent Biopharma Inc
|
AVBP |
0.66%
|
Stoke Therapeutics Inc
|
STOK |
0.66%
|
ProKidney Corp
|
PROK |
0.66%
|
Rapport Therapeutics Inc
|
RAPP |
0.65%
|
Aura Biosciences Inc
|
AURA |
0.65%
|
SpyGlass Pharma Inc
|
SGP |
0.65%
|
WaVe Life Sciences Ltd
|
WVE |
0.64%
|
MoonLake Immunotherapeutics
|
MLTX |
0.64%
|
Immatics NV
|
IMTX |
0.63%
|
Septerna Inc
|
SEPN |
0.63%
|
Invivyd Inc
|
IVVD |
0.62%
|
Adlai Nortye Ltd
|
ANL |
0.62%
|
Cabaletta Bio Inc
|
CABA |
0.62%
|
Bicycle Therapeutics PLC
|
BCYC |
0.62%
|
Tango Therapeutics Inc
|
TNGX |
0.59%
|
Relmada Therapeutics Inc
|
RLMD |
0.58%
|
Crescent Biopharma Inc
|
CBIO |
0.56%
|
Capricor Therapeutics Inc
|
CAPR |
0.52%
|
Evommune Inc
|
EVMN |
0.41%
|
Cash/Cash equivalents
|
Cash.Cash.equivalents |
0.14%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
Virtus LifeSci Biotech Clinical Trials ETF (BBC) share price today is $53.1648.
Yes, Indians can buy shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. To buy BBC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. You can start investing in Virtus LifeSci Biotech Clinical Trials ETF (BBC) with a minimum investment of $1.
The 52-week high price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $54.95. The 52-week low price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $20.52.
The stock symbol (or ticker) of Virtus LifeSci Biotech Clinical Trials ETF is BBC.
Yes, you can setup SIP in Virtus LifeSci Biotech Clinical Trials ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of BBC on the Vested app.
The expense ratio of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 0.79%.
Link copied